Literature DB >> 9153156

Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease.

S Borson1, M A Raskind.   

Abstract

Behavioral symptoms are an integral component of Alzheimer's disease (AD) and an important cause of failure of home care. Well-chosen pharmacologic and psychosocial treatments can improve many of the distressing problem behaviors that occur in the course of the disease and, in some cases, may delay institutionalization. However, controlled trials remain scarce, and prediction of treatment outcome for individual patients is still uncertain at best. Recent improvements in the characterization of behavioral syndromes in AD hold promise for increasing the specificity of treatment choice and the predictability of response. This article reviews features of the major behavioral problems associated with AD and evidence for the effectiveness of existing treatments. We argue that the origins of behavioral disturbances include both intrinsic neurobiological aspects of the disease and environmental provocations, and present an approach to treatment decision-making that respects both the clinician's need to intervene to reduce suffering and the limitations of current knowledge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153156     DOI: 10.1212/wnl.48.5_suppl_6.17s

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

2.  Effects of distinctive encoding on source-based false recognition: further examination of recall-to-reject processes in aging and Alzheimer disease.

Authors:  Benton H Pierce; Jill D Waring; Daniel L Schacter; Andrew E Budson
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

Review 3.  Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel.

Authors:  Helen C Kales; Laura N Gitlin; Constantine G Lyketsos
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

Review 4.  Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability.

Authors:  Giovanni Pennisi; Raffaele Ferri; Giuseppe Lanza; Mariagiovanna Cantone; Manuela Pennisi; Valentina Puglisi; Giulia Malaguarnera; Rita Bella
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

5.  The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings.

Authors:  Joyce Fraker; Helen C Kales; Mary Blazek; Janet Kavanagh; Laura N Gitlin
Journal:  Occup Ther Health Care       Date:  2014-01

Review 6.  A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effects.

Authors:  S S Salek; M D Walker; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

Review 7.  Simulated presence therapy for dementia.

Authors:  Iosief Abraha; Joseph M Rimland; Isabel Lozano-Montoya; Giuseppina Dell'Aquila; Manuel Vélez-Díaz-Pallarés; Fabiana M Trotta; Alfonso J Cruz-Jentoft; Antonio Cherubini
Journal:  Cochrane Database Syst Rev       Date:  2017-04-18

8.  Conceptual fluency at test shifts recognition response bias in Alzheimer's disease: implications for increased false recognition.

Authors:  Carl A Gold; Natalie L Marchant; Wilma Koutstaal; Daniel L Schacter; Andrew E Budson
Journal:  Neuropsychologia       Date:  2007-05-10       Impact factor: 3.139

9.  Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome.

Authors:  James A Bourgeois; Jennifer B Cogswell; David Hessl; Lin Zhang; Michele Y Ono; Flora Tassone; Faraz Farzin; James A Brunberg; Jim Grigsby; Randi J Hagerman
Journal:  Gen Hosp Psychiatry       Date:  2007 Jul-Aug       Impact factor: 3.238

10.  False Memories: The Other Side of Forgetting.

Authors:  Katherine W Turk; Rocco Palumbo; Rebecca G Deason; Anna Marin; Ala'a Elshaar; Emma Gosselin; Maureen K O'Connor; Yorghos Tripodis; Andrew E Budson
Journal:  J Int Neuropsychol Soc       Date:  2020-02-28       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.